Related references
Note: Only part of the references are listed.Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Vera A. Bittner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial
J. Wouter Jukema et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease A Mendelian Randomization Study
Frida Emanuelsson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Role of lipoprotein (a) in peripheral arterial disease
Constantine E. Kosmas et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence: Prospective Data From the Women's Health Study
Aaron W. Aday et al.
CIRCULATION (2018)
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
Sotirios Tsimikas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Marc P. Bonaca et al.
CIRCULATION (2018)
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
Peter Willeit et al.
LANCET (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A Test in Context: Lipoprotein(a) Diagnosis, Prognosis, Controversies, and Emerging Therapies
Sotirios Tsimikas
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature
Francesco Dentali et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Lower Extremity Peripheral Artery Disease and Quality of Life Among Older Individuals in the Community
Aozhou Wu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism
Elena Sticchi et al.
PLOS ONE (2016)
Metabolic syndrome and incident peripheral artery disease - the Multi-Ethnic Study of Atherosclerosis
Himabindu Vidula et al.
ATHEROSCLEROSIS (2015)
Pharmacological Treatment and Current Management of Peripheral Artery Disease
Marc P. Bonaca et al.
CIRCULATION RESEARCH (2015)
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
Gregory G. Schwartz et al.
AMERICAN HEART JOURNAL (2014)
Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts
Anja Laschkolnig et al.
CARDIOVASCULAR RESEARCH (2014)
Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
Amit V. Khera et al.
CIRCULATION (2014)
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry
Dharam J. Kumbhani et al.
EUROPEAN HEART JOURNAL (2014)
Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population
Mark R. Nehler et al.
JOURNAL OF VASCULAR SURGERY (2014)
Lipoprotein(a), polymorphisms in the LPA gene, and incident venous thromboembolism among 21 483 women
J. S. Danik et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
F. Gerald R. Fowkes et al.
LANCET (2013)
Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease The EPIC-Norfolk Prospective Population Study
Deepti Gurdasani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Association between venous and arterial thrombosis: Clinical implications
Massimo Franchini et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2012)
Thrombophilic risk factors and peripheral arterial disease severity
Michelangelo Sartori et al.
THROMBOSIS AND HAEMOSTASIS (2010)
A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
Robert J. Glynn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
C-reactive protein and venous thromboembolism A prospective investigation in the ARIC cohort
Aaron R. Folsom et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Symptomatic peripheral arterial disease in women - Nontraditional biomarkers of elevated risk
Aruna D. Pradhan et al.
CIRCULATION (2008)
National health care costs of peripheral arterial disease in the Medicare population
Alan T. Hirsch et al.
VASCULAR MEDICINE (2008)
One-year cardiovascular event rates in outpatients with atherothrombosis
Ph. Gabriel Steg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Risk factors for declining ankle-brachial index in men and women 65 years or older - The cardiovascular health study
M Kennedy et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study
K Wattanakit et al.
ATHEROSCLEROSIS (2005)
An association between atherosclerosis and venous thrombosis
P Prandoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Cardiovascular risk factors and venous thromboembolism incidence - The longitudinal investigation of thromboembolism etiology
AW Tsai et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Lipoprotein (a) level and mortality in patients with critical lower limb ischaemia
SWK Cheng et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2001)
Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
PM Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
